Cargando…
Discovery of E3 Ligase Ligands for Target Protein Degradation
Target protein degradation has emerged as a promising strategy for the discovery of novel therapeutics during the last decade. Proteolysis-targeting chimera (PROTAC) harnesses a cellular ubiquitin-dependent proteolysis system for the efficient degradation of a protein of interest. PROTAC consists of...
Autores principales: | Lee, Jaeseok, Lee, Youngjun, Jung, Young Mee, Park, Ju Hyun, Yoo, Hyuk Sang, Park, Jongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573645/ https://www.ncbi.nlm.nih.gov/pubmed/36235052 http://dx.doi.org/10.3390/molecules27196515 |
Ejemplares similares
-
Nanobody-targeted E3-ubiquitin ligase complex degrades nuclear proteins
por: Ju Shin, Yeong, et al.
Publicado: (2015) -
Recent Advances in Monitoring Stem Cell Status and Differentiation Using Nano-Biosensing Technologies
por: Kim, Wijin, et al.
Publicado: (2022) -
Electrospun Nanofibrils
Surface-Decorated with Photo-Cross-Linked
Hyaluronic Acid for Cell-Directed Assembly
por: Cho, Wanho, et al.
Publicado: (2022) -
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022) -
Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands
por: Lu, Yingxin, et al.
Publicado: (2021)